|
Hypertension - basic studies
Citations 51-60 of 190 total displayed.
|
Past content
(since Apr 1999):
|
- Vascular Medicine
Glucose-6 Phosphate Dehydrogenase Deficiency Decreases the Vascular Response to Angiotensin II
- Reiko Matsui, Shanqin Xu, Karlene A. Maitland, Antoinette Hayes, Jane A. Leopold, Diane E. Handy, Joseph Loscalzo, and Richard A. Cohen
Circulation 2005;112:257-263; published online before print as doi:10.1161/CIRCULATIONAHA.104.499095
[Abstract]
[Full text]
- Articles
Glucose-6 Phosphate Dehydrogenase Deficiency Decreases the Vascular Response to Angiotensin II
- Reiko Matsui, Shanqin Xu, Karlene A. Maitland, Antoinette Hayes, Jane A. Leopold, Diane E. Handy, Joseph Loscalzo, and Richard A. Cohen
Circulation published July 5, 2005, doi:10.1161/CIRCULATIONAHA.104.499095
[Abstract]
- Hypertension
Improved Myocardial ß-Adrenergic Responsiveness and Signaling With Exercise Training in Hypertension
- Scott M. MacDonnell, Hajime Kubo, Deborah L. Crabbe, Brian F. Renna, Patricia O. Reger, Jun Mohara, L. Ashley Smithwick, Walter J. Koch, Steven R. Houser, and Joseph R. Libonati
Circulation 2005;111:3420-3428; published online before print as doi:10.1161/CIRCULATIONAHA.104.505784
[Abstract]
[Full text]
- Articles
Improved Myocardial  -Adrenergic Responsiveness and Signaling With Exercise Training in Hypertension
- Scott M. MacDonnell, Hajime Kubo, Deborah L. Crabbe, Brian F. Renna, Patricia O. Reger, Jun Mohara, L. Ashley Smithwick, Walter J. Koch, Steven R. Houser, and Joseph R. Libonati
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.505784
[Abstract]
- Hypertension
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
- Carlos M. Ferrario, Jewell Jessup, Mark C. Chappell, David B. Averill, K. Bridget Brosnihan, E. Ann Tallant, Debra I. Diz, and Patricia E. Gallagher
Circulation 2005;111:2605-2610; published online before print as doi:10.1161/CIRCULATIONAHA.104.510461
[Abstract]
[Full text]
- Articles
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
- Carlos M. Ferrario, Jewell Jessup, Mark C. Chappell, David B. Averill, K. Bridget Brosnihan, E. Ann Tallant, Debra I. Diz, and Patricia E. Gallagher
Circulation published May 16, 2005, doi:10.1161/CIRCULATIONAHA.104.510461
[Abstract]
- Editorials
Clinical Significance of Statin Pleiotropic Effects: Hypotheses Versus Evidence
- Michael H. Davidson
Circulation 2005;111:2280-2281, doi:10.1161/01.CIR.0000167560.93138.E7
[Full text]
- Hypertension
Pulmonary Hypertension in a GTP-Cyclohydrolase 1–Deficient Mouse
- Manasi Nandi, Alyson Miller, Raymond Stidwill, Thomas S. Jacques, Amanda A.J. Lam, Sheila Haworth, Simon Heales, and Patrick Vallance
Circulation 2005;111:2086-2090; published online before print as doi:10.1161/01.CIR.0000163268.32638.F4
[Abstract]
[Full text]
- Articles
Pulmonary Hypertension in a GTP-Cyclohydrolase 1-Deficient Mouse
- Manasi Nandi, Alyson Miller, Raymond Stidwill, Thomas S. Jacques, Amanda A.J. Lam, Sheila Haworth, Simon Heales, and Patrick Vallance
Circulation published April 11, 2005, doi:10.1161/01.CIR.0000163268.32638.F4
[Abstract]
- Epidemiology
Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women’s Health Initiative Observational Study
- Barbara V. Howard, Lewis Kuller, Robert Langer, JoAnn E. Manson, Catherine Allen, Annlouise Assaf, Barbara B. Cochrane, Joseph C. Larson, Norman Lasser, Monique Rainford, Linda Van Horn, Marcia L. Stefanick, and Maurizio Trevisan
Circulation 2005;111:1462-1470; published online before print as doi:10.1161/01.CIR.0000159344.21672.FD
[Abstract]
[Full text]
|
|
